4.6 Article

Prognostic Factors of Survival in Glioblastoma Multiforme Patients-A Retrospective Study

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Role of Resection in Glioblastoma Management

Mark W. Youngblood et al.

Summary: Surgery remains a cornerstone of GBM management, with evidence suggesting that increasing extent of resection is associated with better outcomes, but controversies persist regarding the level of benefit and the relationship between resection extent and survival.

NEUROSURGERY CLINICS OF NORTH AMERICA (2021)

Review Clinical Neurology

Advances in the management of glioblastoma

Ruichong Ma et al.

Summary: Glioblastoma is the most common and malignant primary brain tumor in adults, with poor prognosis despite current standard therapy. However, advancements in surgical technology and understanding of the biology of GB have led to increased rates of safe maximal resection and identified potential targets for new treatments like immunotherapy.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Review Pharmacology & Pharmacy

Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance

Wei Wu et al.

Summary: Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor with highly infiltrative nature and treatment resistance, highlighting the importance of innovative treatment strategies. The standard treatment for GBM is surgical resection followed by chemoradiotherapy, but the robust DNA repair and self-renewing capabilities of GBM cells lead to resistance against current therapies.

PHARMACOLOGICAL RESEARCH (2021)

Article Clinical Neurology

Prognostic factors in patients with glioblastoma multiforme: focus on the pathologic variants

Ehsan Alimohammadi et al.

ACTA NEUROLOGICA BELGICA (2020)

Article Clinical Neurology

Over ten years overall survival in glioblastoma: A different disease?

Elisabetta Marton et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)

Article Clinical Neurology

Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma Cohorts

Kristyn Galbraith et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)

Review Biochemistry & Molecular Biology

Novel Molecular Markers in Glioblastoma-Benefits of Liquid Biopsy

Zsuzsanna Birko et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Oncology

Molecular Subgroups of Glioblastoma- an Assessment by Immunohistochemical Markers

Adam Nagy et al.

PATHOLOGY & ONCOLOGY RESEARCH (2019)

Article Oncology

Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma

Eugene Wong et al.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2019)

Article Clinical Neurology

Association of Surgical Resection, Disability, and Survival in Patients with Glioblastoma

Yahya Ahmadipour et al.

JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY (2019)

Article Clinical Neurology

Preoperative Two-Dimensional Size of Glioblastoma is Associated with Patient Survival

Severina Leu et al.

WORLD NEUROSURGERY (2018)

Review Oncology

Adult Glioblastoma

Brian M. Alexander et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Article Oncology

Impact of removed tumor volume and location on patient outcome in glioblastoma

Al-Wala Awad et al.

JOURNAL OF NEURO-ONCOLOGY (2017)

Review Oncology

Survival in glioblastoma: a review on the impact of treatment modalities

P. D. Delgado-Lopez et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2016)

Article Clinical Neurology

Probabilistic Radiographic Atlas of Glioblastoma Phenotypes

B. M. Ellingson et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2013)

Review Oncology

The Definition of Primary and Secondary Glioblastoma

Hiroko Ohgaki et al.

CLINICAL CANCER RESEARCH (2013)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)